在充满挑战的一年中，Actinium ...

An IAEA expert mission was deployed to Suva, Fiji, to support the recovery and transportation of radium-226 to the USA, where the sources will be used as a feedstock to produce actinium-225, an ...

In a challenging year for Actinium Pharmaceuticals (NYSE:ATNM), the company's stock has touched a 52-week low, trading at $1.1, marking an 80% decline from its 52-week high of $10.24. According to ...

Actinium Pharma is on course to submit its targeted radiotherapy for acute myeloid leukaemia (AML) patients needing a bone marrow transplant in the US, buoyed by top-line data from a pivotal trial ...

Actinium Pharma has revealed the data from its SIERRA trial of radioligand therapy Iomab-B for acute myeloid leukaemia (AML) patients needing a bone marrow transplant, bolstering the case for the ...

Why Palantir Technologies Shares Are Trading Higher By Around 10%; Here Are 20 Stocks Moving Premarket ...

Actinium Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company, which engages in the development of novel targeted therapies. It also develops and markets medicines for relapsed or ...

This page features the latest news about the Actinium Pharmaceuticals stock. ATNM stock touches 52-week low at $1.17 amid market challenges In a challenging market environment, Actinium ...

Actinium Pharmaceuticals (NYSE:ATNM) closed the most recent trading day at $11.16, moving -1.06% from the previous trading session. This change lagged the S&P 500's ...